What is Ecovative?
Founded in 2007 by Eben Bayer and Gavin McIntyre, Ecovative has established itself as a leader in mycelium technology. The company designs and cultivates sustainable materials that leverage the natural growth of fungi to create high-performance alternatives to conventional products. Ecovative's Mycelium Foundry produces fully formed structures that rival the performance of plastics and leather, with the added environmental benefit of biodegradability, turning to compost at the end of their lifecycle. This innovative approach addresses the growing demand for sustainable solutions without the associated environmental costs, stemming from an initial concept developed at Rensselaer Polytechnic Institute.
How much funding has Ecovative raised?
Ecovative has raised a total of $71.3M across 3 funding rounds:
Debt
$350K
Series D
$60M
Other Financing Round
$11M
Debt (2020): $350K with participation from PPP
Series D (2021): $60M led by Viking Global Investors, Senator Investment Group, Trousdale Ventures, and AiiM Partners
Other Financing Round (2025): $11M supported by Advance Albany County Alliance
Key Investors in Ecovative
Advance Albany County Alliance
The Advance Albany County Alliance is a Local Development Corporation focused on fostering business development and growth within Albany County, providing support for business expansion and talent attraction.
Viking Global Investors
Viking Global Investors is a global investment firm that employs a research-intensive, long-term investment strategy, focusing on fundamental analysis across various industries and geographies.
Senator Investment Group
Senator Investment Group is an investment firm that likely focuses on strategic capital allocation and growth opportunities within its portfolio companies.
What's next for Ecovative?
With a recent major strategic investment and a substantial overall funding base of $71.4M, Ecovative is poised for accelerated scaling and market penetration. The 'major enterprise-level funding' context suggests a focus on expanding manufacturing capabilities, forging new strategic partnerships, and potentially entering new global markets. This capital infusion will likely fuel further research and development into novel mycelium applications, solidifying Ecovative's position as a key player in the circular economy and sustainable materials industry. The company's trajectory indicates a strong commitment to displacing environmentally harmful materials with biodegradable, nature-based solutions.
See full Ecovative company page
